These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

902 related articles for article (PubMed ID: 20831538)

  • 21. Drug-induced hypersensitivity syndrome due to mexiletine hydrochloride associated with reactivation of human herpesvirus 7.
    Yagami A; Yoshikawa T; Asano Y; Koie S; Shiohara T; Matsunaga K
    Dermatology; 2006; 213(4):341-4. PubMed ID: 17135743
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Naproxen-induced generalized bullous fixed drug eruption.
    Bandino JP; Wohltmann WE; Bray DW; Hoover AZ
    Dermatol Online J; 2009 Nov; 15(11):4. PubMed ID: 19951640
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Sulfasalazine-induced hypersensitivity syndrome associated with human herpesvirus 6 reactivation and induction of antiphospholipid syndrome].
    Tung Y; Escutia B; Blanes M; Navarrro M; Pujol C
    Actas Dermosifiliogr; 2011 Sep; 102(7):537-40. PubMed ID: 21435627
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The variable clinical picture of drug-induced hypersensitivity syndrome/drug rash with eosinophilia and systemic symptoms in relation to the eliciting drug.
    Kano Y; Shiohara T
    Immunol Allergy Clin North Am; 2009 Aug; 29(3):481-501. PubMed ID: 19563993
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug-induced hypersensitivity syndrome with human herpesvirus-6 reactivation.
    Riyaz N; Sarita S; Arunkumar G; Sabeena S; Manikoth N; Sivakumar CP
    Indian J Dermatol Venereol Leprol; 2012; 78(2):175-7. PubMed ID: 22421649
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Codeine phosphate-induced hypersensitivity syndrome.
    Enomoto M; Ochi M; Teramae K; Kamo R; Taguchi S; Yamane T
    Ann Pharmacother; 2004 May; 38(5):799-802. PubMed ID: 15010521
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pulmonary hemosiderosis with juvenile rheumatoid arthritis: a case report.
    Topaloğlu R; Kiper N; Göçmen A; Varan B; Saatçi U
    Turk J Pediatr; 2000; 42(2):148-50. PubMed ID: 10936982
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Another patient with chromosome 18 deletion syndrome and juvenile rheumatoid arthritis.
    Rosen P; Hopkin RJ; Glass DN; Graham TB
    J Rheumatol; 2004 May; 31(5):998-1000. PubMed ID: 15124264
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Naproxen induced pustular eruption.
    Banerjee T; Konar MC
    Indian Pediatr; 2009 May; 46(5):432-3. PubMed ID: 19478360
    [No Abstract]   [Full Text] [Related]  

  • 30. Severe hypersensitivity syndrome due to sulfasalazine associated with reactivation of human herpesvirus 6.
    Tohyama M; Yahata Y; Yasukawa M; Inagi R; Urano Y; Yamanishi K; Hashimoto K
    Arch Dermatol; 1998 Sep; 134(9):1113-7. PubMed ID: 9762024
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug reaction with eosinophilia and systemic symptoms without skin rash.
    Sasidharanpillai S; Binitha MP; Manikath N; Janardhanan AK
    Indian J Pharmacol; 2015; 47(6):687-9. PubMed ID: 26729967
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hemophagocytic syndrome occurring in polyarticular juvenile arthritis treated by salazopyrine].
    Bouayed K; Brik H; Zakari A; Mikou N; Dehbi F
    Arch Pediatr; 2006 Aug; 13(8):1156-7. PubMed ID: 16793243
    [No Abstract]   [Full Text] [Related]  

  • 33. Association of human herpesvirus 6 reactivation with the flaring and severity of drug-induced hypersensitivity syndrome.
    Tohyama M; Hashimoto K; Yasukawa M; Kimura H; Horikawa T; Nakajima K; Urano Y; Matsumoto K; Iijima M; Shear NH
    Br J Dermatol; 2007 Nov; 157(5):934-40. PubMed ID: 17854362
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): an atypical case during treatment with sulfasalazine.
    Famularo G; Bravi MC; Gasbarrone L; Minisola G
    Clin Exp Rheumatol; 2013; 31(2):326-7. PubMed ID: 23406887
    [No Abstract]   [Full Text] [Related]  

  • 35. DRESS syndrome associated with carbamazepine and phenytoin.
    Allam JP; Paus T; Reichel C; Bieber T; Novak N
    Eur J Dermatol; 2004; 14(5):339-42. PubMed ID: 15358574
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Naproxen-associated renal failure in a child with arthritis and inflammatory bowel disease.
    Laxer RM; Silverman ED; Balfe JW; Poucell S; Baumal R
    Pediatrics; 1987 Dec; 80(6):904-8. PubMed ID: 3684403
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Drug reaction with eosinophilia and systemic symptoms (DRESS)].
    Descamps V
    Rev Prat; 2012 Dec; 62(10):1347-52. PubMed ID: 23424909
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sulfasalazine treatment in juvenile chronic arthritis: an open study.
    Joos R; Veys EM; Mielants H; van Werveke S; Goemaere S
    J Rheumatol; 1991 Jun; 18(6):880-4. PubMed ID: 1680193
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Naproxen-induced fixed drug eruption: a case report.
    Akyazi H; Baltaci D; Mungan S; Kara IH
    Hum Exp Toxicol; 2011 Nov; 30(11):1872-4. PubMed ID: 21357631
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Naproxen-induced anemia and hypoalbuminemia in a 16-month-old child.
    Boodhan S; Friedman JN
    Clin Pediatr (Phila); 2009 Jan; 48(1):96-8. PubMed ID: 18632553
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 46.